Amphotericin B Patent Expiration
Amphotericin B was first introduced by Apothecon Inc Div Bristol Myers Squibb
Amphotericin B Patents
Given below is the list of patents protecting Amphotericin B, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Abelcet | US5616334 | Low toxicity drug-lipid systems |
Apr 01, 2014
(Expired) | Leadiant Biosci Inc |
Abelcet | US6406713 | Methods of preparing low-toxicity drug-lipid complexes |
Jun 18, 2019
(Expired) | Leadiant Biosci Inc |
Ambisome | US5874104 | Treatment of systemic fungal infections with phospholipid particles encapsulating polyene antibiotics |
Feb 23, 2016
(Expired) | Astellas |
Ambisome | US5965156 | Amphotericin B liposome preparation |
Oct 12, 2016
(Expired) | Astellas |
Try Our Curated Drug Screens
Amphotericin B Generics
Several generic applications have been filed for Amphotericin B. The first generic version for Amphotericin B was by Apothecon Inc Div Bristol Myers Squibb and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Nov 17, 2022.
Given below is the list of companies who have filed for Amphotericin B generic.
1. ABBOTT
Abbott Laboratories has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Abbott.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/VIAL | injectable | Discontinued | INJECTION | N/A | Dec 23, 1996 |
2. ABRAXIS PHARM
Abraxis Pharmaceutical Products has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/VIAL | injectable | Discontinued | INJECTION | N/A | Apr 13, 1987 |
3. APOTHECON
Apothecon Inc Div Bristol Myers Squibb has filed for 2 different strengths of generic version for Amphotericin B. All of these versions come by the name FUNGIZONE. Given below are the details of the strengths of this generic introduced by Apothecon.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/VIAL | injectable | Discontinued | INJECTION | N/A | Approved Prior to Jan 1, 1982 |
3% | lotion | Discontinued | TOPICAL | N/A | Approved Prior to Jan 1, 1982 |
4. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/VIAL | injectable, liposomal | Prescription | INJECTION | AB | Nov 17, 2022 |
5. SPIL
Sun Pharma Industries Ltd has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Spil.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/VIAL | injectable, liposomal | Prescription | INJECTION | AB | Dec 14, 2021 |
6. TEVA PARENTERAL
Teva Parenteral Medicines Inc has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Teva Parenteral.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/VIAL | injectable | Discontinued | INJECTION | N/A | Mar 31, 1995 |
7. XGEN PHARMS
Xgen Pharmaceuticals Djb Inc has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Xgen Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG/VIAL
(reference standard) | injectable | Prescription | INJECTION | N/A | Apr 29, 1992 |